| Company Name: |
ShangHai Caerulum Pharma Discovery Co., Ltd.
|
| Tel: |
18149758185 18149758185 |
| Email: |
sales-cpd@caerulumpharma.com |
| Products Intro: |
Product Name:K-Ras G12C-IN-4 CAS:2376328-55-9 Purity:98% Package:10mg;100mg;1g;10g;100g;1kg Remarks:1g
|
| Company Name: |
Shanghai YuanYe Biotechnology Co., Ltd.
|
| Tel: |
021-61312847; 18021002903 |
| Email: |
3008007409@qq.com |
| Products Intro: |
Product Name:K-Ras G12C-IN-4 CAS:2376328-55-9 Package:1ml Remarks:T97385
|
| Company Name: |
Shanghai SuperLan Chemcial Technique Centre
|
| Tel: |
0-2022843681 15618226720 |
| Email: |
chaolaichem@foxmail.com |
| Products Intro: |
Product Name:K-RAS G12C-IN-4 CAS:2376328-55-9 Purity:95 Package:1G,5G,10G,50G,100G,1KG
|
|
| | K-Ras G12C-IN-4 Basic information |
| Product Name: | K-Ras G12C-IN-4 | | Synonyms: | K-Ras G12C-IN-4;1H-Indole-1-acetamide, 5-chloro-2-cyclopropyl-3-[(3,4-dihydro-5-methoxy-2(1H)-isoquinolinyl)carbonyl]-7-methyl-N-[1-(1-oxo-2-propen-1-yl)-3-azetidinyl]-;Inhibitor,K Ras G12C IN 4,inhibit,Ras,K-Ras G-12C-IN-4,KRas G12CIN4;K-Ras G12C-IN-4, 10 mM in DMSO | | CAS: | 2376328-55-9 | | MF: | C31H33ClN4O4 | | MW: | 561.07 | | EINECS: | | | Product Categories: | | | Mol File: | 2376328-55-9.mol |  |
| | K-Ras G12C-IN-4 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO : 62.5 mg/mL (111.39 mM; ultrasonic and warming and heat to 60°C) | | form | Solid | | color | White to off-white |
| | K-Ras G12C-IN-4 Usage And Synthesis |
| Uses | K-Ras G12C-IN-4, compound 1, is a potent Covalent Inhibitor of KRASG12C[1]. | | Biological Activity | K-Ras G12C-IN-4, compound 1, is a potent Covalent Inhibitor of KRASG12C[1].
K-Ras G12C-IN-4 (4 hours) exhibits IC50=0.219 μM for inhibition of MAPK signaling (p-ERK) in MIA PaCa-2 cells[1].K-Ras G12C-IN-4 (72 hours) translates to a 0.067 μM IC50 for inhibition of cellular viability in a CellTiter-Glo experiment in MIA PaCa-2 cells[1]. | | References | [1]. Shin Y, et al. Discovery of N-(1-Acryloylazetidin-3-yl)-2-(1H-indol-1-yl)acetamides as Covalent Inhibitors of KRASG12C. ACS Med Chem Lett. 2019 Aug 20;10(9):1302-1308. |
| | K-Ras G12C-IN-4 Preparation Products And Raw materials |
|